Source: centralcharts

Press Release: Biosensors : Blue Sail Medical and Biosensors International enter the Structural Heart market with the acquisition of Switzerland based NVT AG.

Read full article »

Biosensors's Competitors | Biosensors's News | Biosensors's Financials

Followers on Owler

2,107

Est. Annual Revenue

$100-500M

Est. Employees

250-500

CEO

Brian Fan Yang

CEO Approval Rating

81/100

Biosensors is a medical device company that specializes in developing and manufacturing cardiology technologies and critical care.